Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -33.29x is in line with its 4-year average of -34.87x, near the high end of its 4-year range (-10771.00x–-5.35x).
11.99% below its 12-month average of -29.72x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -25.44x.
INTEREST COVERAGE RATIO
-33.29x
INTEREST COVERAGE RATIO AVG TTM
-29.72x
INTEREST COVERAGE RATIO AVG 3Y
-78.27x
INTEREST COVERAGE RATIO AVG 5Y
-34.87x
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-11.99%
CURRENT VS 3Y AVG
+57.47%
CURRENT VS 5Y AVG
+4.52%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.54x
median of 432 covered companies
CURRENT VS SECTOR MEDIAN
-500.90%
vs the sector median at left
Elicio Therapeutics, Inc.
Market Cap
$36.80M
Interest Coverage Ratio
-33.29x
TTM Avg
-29.72x
3Y Avg
-78.27x
5Y Avg
-34.87x
Market Cap
$37.28M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$36.25M
Interest Coverage Ratio
47.58x
TTM Avg
47.58x
3Y Avg
47.58x
5Y Avg
47.58x
Market Cap
$35.76M
Interest Coverage Ratio
-87.92x
TTM Avg
13.24x
3Y Avg
16.68x
5Y Avg
16.68x
Market Cap
$38.35M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$35.15M
Interest Coverage Ratio
-735.69x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$39.10M
Interest Coverage Ratio
-0.13x
TTM Avg
0.53x
3Y Avg
0.64x
5Y Avg
0.43x
Market Cap
$34.48M
Interest Coverage Ratio
-0.75x
TTM Avg
0.33x
3Y Avg
0.47x
5Y Avg
0.65x
Market Cap
$34.34M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Elicio Therapeutics, Inc. (ELTX) | $36.80M | -33.29x | -29.72x | -78.27x | -34.87x |
| Edesa Biotech, Inc. (EDSA)vs › | $37.28M | N/A | N/A | N/A | N/A |
| Elutia Inc (ELUT)vs › | $36.25M | 47.58x | 47.58x | 47.58x | 47.58x |
| DocGo Inc. (DCGO)vs › | $35.76M | -87.92x | 13.24x | 16.68x | 16.68x |
| Incannex Healthcare Limited (IXHL)vs › | $38.35M | N/A | N/A | N/A | N/A |
| BriaCell Therapeutics Corp. (BCTX)vs › | $35.15M | -735.69x | N/A | N/A | N/A |
| Harvard Bioscience, Inc. (HBIO)vs › | $39.10M | -0.13x | 0.53x | 0.64x | 0.43x |
| Accuray Incorporated (ARAY)vs › | $34.48M | -0.75x | 0.33x | 0.47x | 0.65x |
| Grace Therapeutics, Inc. (GRCE)vs › | $34.34M | N/A | N/A | N/A | N/A |
| Aligos Therapeutics, Inc. (ALGS)vs › | $34.04M | N/A | N/A | N/A | N/A |
Interest Coverage
-33.3x
Debt/Equity
1.78
Current Ratio
2.77
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -25.44x |
| 2026-03-31 | -26.05x |
| 2025-12-31 | -26.24x |
| 2025-09-30 | -18.88x |
| 2025-06-30 | -52.02x |
| 2025-03-31 | -61.00x |
| 2024-12-31 | -57.59x |
| 2024-09-30 | -75.50x |
| 2024-06-30 | -222.94x |
| 2024-03-31 | -284.47x |
| 2023-12-31 | -4696.00x |
| 2023-09-30 | -10771.00x |
| 2023-06-30 | -10.89x |
| 2023-03-31 | -22.82x |
| 2022-12-31 | -65.62x |
| 2022-09-30 | -5.35x |
| 2022-06-30 | -5.84x |
| 2020-12-31 | -2.47x |
| 2020-09-30 | -4.49x |
| 2020-06-30 | -35.46x |
